ARCHIVES

Satraplatin With Prednisone Reduces Risk Of Disease Progression By 33% In Study

This article is from The Cancer Letter archive.

Vol. 30 No. 3 | March 30, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: Breast Cancer Projects To Pay For Concurrent Pathology Review; Laetrile Study Entry Closed

May 19, 1978

DCT Board Approves $8 Million In Contract Projects For Recompetition

October 31, 1980

Dose Dense Chemo Study Published Early; Method Improves Breast Cancer Survival

February 28, 2003

Ohio Legislature Gives $1 Million To Cancer Control

August 19, 1983

In Brief: Oldham to Leave NCI, Herberman Acting Head Of BRMP; Lansky Appointed Director Of ICC

November 11, 1983

DCT Board Insists On Being Heard In Development Of CCOP Guidelines

February 19, 1982